Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

The European Commission has approved Wayrilz, a novel, oral, reversible, Bruton’s tyrosine kinase inhibitor, as a new treatment for immune ...

LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company developing first-in-class, orally delivered immune-tolerance-restoring therapies, announced today that the first patient ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Abstract: Two-level three-phase voltage-source inverters are widely used in permanent magnet synchronous motor-drive systems. Using pulsewidth modulation (PWM) for control will generate a common-mode ...

“Photon Design's next-generation, EPIPPROP simulator, will offer the flexibility to split waveguides, simulating this process ...

With this milestone, Mondego Bio is transitioning into clinical-stage operations and plans to initiate a first-in-human (FIH) Phase 1 clinical study in the first half of 2026.

Abstract: The typical strategy for the phase-shifted full-bridge (PSFB) converter is to design a linear compensator based on a small-signal model. However, this approach cannot provide a strongly ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

The Phase 1b study is designed to evaluate the safety and tolerability of orally administered balomenib over a 28-day treatment period, followed by a post-treatment observation phase of up to ...

Ripples maintain time-locked occurrence across the septo-temporal axis and hemispheres while showing local phase coupling, revealing a dual mode of synchrony in CA1 network dynamics.

Dr. Khalil Choucair specializes in cancers of the chest, including lung cancerDETROIT, Dec. 17, 2025 /PRNewswire/ -- The ...